Ribomic, Inc. (4591) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Wakamoto Pharmaceutical Co., Ltd.

Perseus Proteomics, Inc.

Kainos Laboratories, Inc.

Solasia Pharma KK

Nippon Chemiphar Co., Ltd.

Pharmarise Holdings Corp.

Kubota Pharmaceutical Holdings Co. Ltd.

D. Western Therapeutics Institute, Inc.

Renascience, Inc.

Ribomic, Inc.

Delta-Fly Pharma, Inc.

Why is Ribomic, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Ribomic, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Ribomic, Inc.

-8.65%

0.07

65.77%

Japan Nikkei 225

40.96%

1.35

28.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-55.53%

EBIT Growth (5y)

-3.17%

EBIT to Interest (avg)

-1,286.40

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.00

Sales to Capital Employed (avg)

0.01

Tax Ratio

0.11%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.32

EV to EBIT

-0.93

EV to EBITDA

-0.93

EV to Capital Employed

150.27

EV to Sales

464.23

PEG Ratio

Dividend Yield

ROCE (Latest)

-16140.56%

ROE (Latest)

-33.38%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

NET SALES(HY)

At JPY 0.75 MM has Grown at 23.56%

NET PROFIT(HY)

Higher at JPY -535.84 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 0.94 times

EPS(Q)

Highest at JPY -4.68

-5What is not working for the Company

NET SALES(9M)

At JPY 0.75 MM has Grown at -64.4%

RAW MATERIAL COST(Y)

Grown by 6,147% (YoY

Here's what is working for Ribomic, Inc.

Net Sales

At JPY 0.75 MM has Grown at 23.56%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (JPY MM)

Net Profit

Higher at JPY -535.84 MM

than preceding 12 month period ended Dec 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (JPY MM)

EPS

Highest at JPY -4.68

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Inventory Turnover Ratio

Highest at 0.94 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Depreciation

Highest at JPY 1.21 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Ribomic, Inc.

Raw Material Cost

Grown by 6,147% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales